Do patients with pancreatic body or tail cancer benefit from adjuvant therapy?A cohort study

Our study suggests that the benefit of adjunctive Rx is restricted to pancreatic head tumors; body and tail tumors have a much better prognosis. These results warrant further evaluation in prospective studies.